Immunopathogenesis of Hepatitis E Virus Infection

Abstract

The course of hepatitis E virus infection (HEV) can vary substantially between different individuals. Although most infections take a clinically silent asymptomatic course, a few patients may develop severe hepatitis that can progress to fulminant hepatic failure. In addition, cases of chronic hepatitis E have been described in immunosuppressed patients. The detailed mechanisms leading to different clinical outcomes of HEV infection are only partially understood. Both viral factors including the HEV genotype and the dose of the infectious inoculum, as well as host factors such as stage of liver disease, pregnancy or distinct genetic polymorphisms determine the course of HEV infection. Recent studies were able to associate T-cell responses, activation of the interferon system and viral evolution with severity or chronicity of hepatitis E. We here summarize the emerging data on the immunopathogenesis of HEV infection.

Keywords

hepatitis E virus - HEV - T-cell responses - humoral immunity - animal models

• References

• 1 Kamar N, Bendall R, Legrand-Abravanel F , et al. Hepatitis E. Lancet 2012; 379 (9835) 2477-2488
• 2 Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology 2012; 142 (6) 1388-1397 , e1
• 3 Aggarwal R, Jameel S. Hepatitis E. Hepatology 2011; 54 (6) 2218-2226
• 4 Mahtab MA, Rahman S, Khan M, Karim MF. Hepatitis E virus is a leading cause of acute-on-chronic liver disease: experience from a tertiary centre in Bangladesh. Hepatobiliary Pancreat Dis Int 2009; 8 (1) 50-52
• 5 Péron JM, Bureau C, Poirson H , et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007; 14 (5) 298-303
• 6 Kamar N, Selves J, Mansuy JM , et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358 (8) 811-817
• 7 Haagsma EB, Niesters HG, van den Berg AP , et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009; 15 (10) 1225-1228
• 8 Pischke S, Suneetha PV, Baechlein C , et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010; 16 (1) 74-82
• 9 Kamar N, Garrouste C, Haagsma EB , et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140 (5) 1481-1489
• 10 Pischke S, Stiefel P, Franz B , et al. Chronic hepatitis e in heart transplant recipients. Am J Transplant 2012; 12 (11) 3128-3133
• 11 Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse?. Hepatology 2008; 48 (5) 1577-1585
• 12 Bose PD, Das BC, Kumar A, Gondal R, Kumar D, Kar P. High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome. J Hepatol 2011; 54 (6) 1107-1113
• 13 Divizia M, Gabrieli R, Degener AM , et al. Evidence of hepatitis E virus replication on cell cultures. New Microbiol 1999; 22 (2) 77-83
• 14 Zhang HY, Chen DS, Wu YQ, He QG, Chen HC, Liu ZF. Both swine and human cells are capable to support the replication of swine hepatitis E virus type 4 in vitro. Virus Res 2011; 158 (1-2) 289-293
• 15 Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 2010; 10 (11) 753-766
• 16 Protzer U, Maini MK, Knolle PA. Living in the liver: hepatic infections. Nat Rev Immunol 2012; 12 (3) 201-213
• 17 Lunemann S, Schlaphoff V, Cornberg M, Wedemeyer H. NK cells in hepatitis C: role in disease susceptibility and therapy. Dig Dis 2012; 30 (Suppl. 01) 48-54
• 18 Stegmann KA, Björkström NK, Veber H , et al. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 2010; 138 (5) 1885-1897
• 19 Stegmann KA, Björkström NK, Ciesek S , et al. Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1. J Infect Dis 2012; 205 (9) 1351-1362
• 20 Peppa D, Gill US, Reynolds G , et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med 2013; 210 (1) 99-114
• 21 Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012; 481 (7381) 394-398
• 22 Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284 (5415) 825-829
• 23 Guidotti LG, Borrow P, Brown A, McClary H, Koch R, Chisari FV. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med 1999; 189 (10) 1555-1564
• 24 Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 65-91
• 25 Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009; 119 (7) 1745-1754
• 26 Klenerman P, Thimme R. T cell responses in hepatitis C: the good, the bad and the unconventional. Gut 2012; 61 (8) 1226-1234
• 27 Krawczynski K, Meng XJ, Rybczynska J. Pathogenetic elements of hepatitis E and animal models of HEV infection. Virus Res 2011; 161 (1) 78-83
• 28 Tsarev SA, Tsareva TS, Emerson SU , et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A 1994; 91 (21) 10198-10202
• 29 Shata MT, Daef EA, Zaki ME , et al. Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt. Trans R Soc Trop Med Hyg 2012; 106 (10) 613-618
• 30 Zhang J, Gu Y, Ge SX , et al. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 2005; 23 (22) 2881-2892
• 31 Schofield DJ, Glamann J, Emerson SU, Purcell RH. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol 2000; 74 (12) 5548-5555
• 32 Engle RE, Yu C, Emerson SU, Meng XJ, Purcell RH. Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol 2002; 40 (12) 4576-4580
• 33 Zhang J, Li SW, Wu T, Zhao Q, Ng MH, Xia NS. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity. Rev Med Virol 2012; 22 (5) 339-349
• 34 Shrestha MP, Scott RM, Joshi DM , et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356 (9) 895-903
• 35 Zhu FC, Zhang J, Zhang XF , et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376 (9744) 895-902
• 36 Arankalle VA, Favorov MO, Chadha MS, Phule DM, Banerjee K. Rhesus monkeys infected with hepatitis E virus (HEV) from the former USSR are immune to subsequent challenge with an Indian strain of HEV. Acta Virol 1993; 37 (6) 515-518
• 37 Torresi J, Johnson D, Wedemeyer H. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. J Hepatol 2011; 54 (6) 1273-1285
• 38 Aggarwal R, Shukla R, Jameel S , et al. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J Viral Hepat 2007; 14 (4) 283-292
• 39 Wu T, Zhang J, Su ZJ , et al. Specific cellular immune response in hepatitis E patients. Intervirology 2008; 51 (5) 322-327
• 40 Husain MM, Aggarwal R, Kumar D, Jameel S, Naik S. Effector T cells immune reactivity among patients with acute hepatitis E. J Viral Hepat 2011; 18 (10) e603-e608
• 41 Tripathy AS, Das R, Rathod SB, Arankalle VA. Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection. PLoS ONE 2012; 7 (2) e31822
• 42 Srivastava R, Aggarwal R, Sachdeva S, Alam MI, Jameel S, Naik S. Adaptive immune responses during acute uncomplicated and fulminant hepatitis E. J Gastroenterol Hepatol 2011; 26 (2) 306-311
• 43 Lhomme S, Abravanel F, Dubois M , et al. Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J Virol 2012; 86 (18) 10006-10014
• 44 Suneetha PV, Pischke S, Schlaphoff V , et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012; 55 (3) 695-708
• 45 Timm J, Li B, Daniels MG , et al. Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology 2007; 46 (2) 339-349
• 46 TrehanPati N, Kotillil S, Hissar SS , et al. Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate. J Clin Immunol 2011; 31 (3) 509-520
• 47 Dunn C, Brunetto M, Reynolds G , et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007; 204 (3) 667-680
• 48 Srivastava R, Aggarwal R, Bhagat MR, Chowdhury A, Naik S. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. J Viral Hepat 2008; 15 (12) 910-916
• 49 Tripathy AS, Das R, Rathod SB, Gurav YK, Arankalle VA. Peripheral T regulatory cells and cytokines in hepatitis E infection. Eur J Clin Microbiol Infect Dis 2012; 31 (2) 179-184
• 50 Yu C, Boon D, McDonald SL , et al. Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J Virol 2010; 84 (21) 11264-11278
• 51 Dong C, Zafrullah M, Mixson-Hayden T , et al. Suppression of interferon-α signaling by hepatitis E virus. Hepatology 2012; 55 (5) 1324-1332
• 52 Emerson SU, Purcell RH. Recombinant vaccines for hepatitis E. Trends Mol Med 2001; 7 (10) 462-466
• 53 Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48 (3) 494-503
• 54 McCaustland KA, Krawczynski K, Ebert JW , et al. Hepatitis E virus infection in chimpanzees: a retrospective analysis. Arch Virol 2000; 145 (9) 1909-1918
• 55 Meng XJ, Purcell RH, Halbur PG , et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 1997; 94 (18) 9860-9865
• 56 Halbur PG, Kasorndorkbua C, Gilbert C , et al. Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol 2001; 39 (3) 918-923
• 57 Feagins AR, Opriessnig T, Huang YW, Halbur PG, Meng XJ. Cross-species infection of specific-pathogen-free pigs by a genotype 4 strain of human hepatitis E virus. J Med Virol 2008; 80 (8) 1379-1386
• 58 Huang F, Hua X, Yang S, Yuan C, Zhang W. Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase. Antiviral Res 2009; 83 (3) 274-281
• 59 Maneerat Y, Clayson ET, Myint KS, Young GD, Innis BL. Experimental infection of the laboratory rat with the hepatitis E virus. J Med Virol 1996; 48 (2) 121-128
• 60 Zhao C, Ma Z, Harrison TJ , et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol 2009; 81 (8) 1371-1379
• 61 Aggarwal R, Kamili S, Spelbring J, Krawczynski K. Experimental studies on subclinical hepatitis E virus infection in cynomolgus macaques. J Infect Dis 2001; 184 (11) 1380-1385
• 62 Bradley DW, Balayan MS. Virus of enterically transmitted non-A, non-B hepatitis. Lancet 1988; 1 (8589) 819
• 63 Arankalle V, Banerjee K. Viruses of enterically transmitted non-A, non-B hepatitis. Lancet 1988; 2 (8603) 160
• 64 Krawczynski K, Bradley DW. Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J Infect Dis 1989; 159 (6) 1042-1049
• 65 Ticehurst J, Rhodes Jr LL, Krawczynski K , et al. Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from Mexico. J Infect Dis 1992; 165 (5) 835-845
• 66 Shata MT, Barrett A, Shire NJ , et al. Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay. J Immunol Methods 2007; 328 (1-2) 152-161
• 67 Soe S, Uchida T, Suzuki K , et al. Enterically transmitted non-A, non-B hepatitis in cynomolgus monkeys: morphology and probable mechanism of hepatocellular necrosis. Liver 1989; 9 (3) 135-145
• 68 Peron JM, Danjoux M, Kamar N , et al. Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from South-West France. Virchows Arch 2007; 450 (4) 405-410
• 69 Malcolm P, Dalton H, Hussaini HS, Mathew J. The histology of acute autochthonous hepatitis E virus infection. Histopathology 2007; 51 (2) 190-194
• 70 Wendum D, Nachury M, Yver M , et al. Acute hepatitis E: a cause of lymphocytic destructive cholangitis. Hum Pathol 2005; 36 (4) 436-438
• 71 Agrawal V, Goel A, Rawat A, Naik S, Aggarwal R. Histological and immunohistochemical features in fatal acute fulminant hepatitis E. Indian J Pathol Microbiol 2012; 55 (1) 22-27
• 72 Prabhu SB, Gupta P, Durgapal H , et al. Study of cellular immune response against hepatitis E virus (HEV). J Viral Hepat 2011; 18 (8) 587-594
• 73 Kar P, Jilani N, Husain SA , et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy?. Am J Gastroenterol 2008; 103 (10) 2495-2501
• 74 Jilani N, Das BC, Husain SA , et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol 2007; 22 (5) 676-682
• 75 Mishra N, Arankalle VA. Association of polymorphisms in the promoter regions of TNF-ά with susceptibility to hepatitis E virus and TNF-α (-1031) and IFN-y (+874) genes with clinical outcome of hepatitis E in India. J Hepatol 2011; 55: 1227-1234
• 76 Wu T, Zhu FC, Huang SJ , et al. Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis. Hepatology 2012; 55 (6) 2038
• 77 Kamar N, Weclawiak H, Guilbeau-Frugier C , et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 2012; 93 (6) 617-623
• 78 Kamar N, Bendall RP, Peron JM , et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011; 17 (2) 173-179
• 79 Kammer AR, van der Burg SH, Grabscheid B , et al. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med 1999; 190 (2) 169-176
• 80 Pischke S, Hardtke S, Bode U , et al. Ribavirin treatment of acute and chronic hepatitis E: a single center experience. Liver International 2013; ; in press
• 81 Moal V, Textoris J, Ben Amara A , et al. Chronic hepatitis E virus infection is specifically associatd with an interferon-related transcriptional program. J Infect Dis 2013; 207 (1) 125-132